Form 4 for VOR Vor Biopharma Inc.
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-01 · accession 0001415889-24-026127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-05 | 2024-11-01 | VOR | Attar Eyal C. | Chief MEDICAL Off | F - Tax | $0.8 | -1,146 | 92.8K | -1% | -$916.80 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-01 | F | D | 1,146 | $0.8 | 92,772 | D | — | — | (F1) Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. |